Narcotic use for inflammatory bowel disease and risk factors during hospitalization:

Abstract

Growing evidence demonstrates adverse effects of narcotics in inflammatory bowel disease (IBD). We sought to study the relationship between narcotic use, objective measures of disease activity and other associated factors in hospitalized patients with IBD